Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Assessment of acute aerobic exercise in the morning versus evening on asprosin, spexin, lipocalin-2, and insulin level in overweight/obese versus normal weight adult men
Halil İ̇brahim Ceylan, Özcan SAYGIN, Ümmühani Özel Türkçü
Chronobiology International (2020) Vol. 37, Iss. 8, pp. 1252-1268
Closed Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Asprosin in health and disease, a new glucose sensor with central and peripheral metabolic effects
Mariam Farrag, Djedjiga Ait Eldjoudi, María González‐Rodriguez, et al.
Frontiers in Endocrinology (2023) Vol. 13
Open Access | Times Cited: 38
Adipose–Muscle crosstalk in age-related metabolic disorders: The emerging roles of adipo-myokines
Penghua Fang, Yuqing She, Mei Yu, et al.
Ageing Research Reviews (2022) Vol. 84, pp. 101829-101829
Closed Access | Times Cited: 30
Sensitive asprosin detection in clinical samples reveals serum/saliva correlation and indicates cartilage as source for serum asprosin
Yousef Ashraf Tawfik Morcos, Steffen Lütke, Antje Tenbieg, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 29
Enhancing cardiometabolic health: unveiling the synergistic effects of high-intensity interval training with spirulina supplementation on selected adipokines, insulin resistance, and anthropometric indices in obese males
Maryam Delfan, Ayoub Saeidi, Rashmi Supriya, et al.
Nutrition & Metabolism (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Exercise‐induced appetite suppression: An update on potential mechanisms
Seth F. McCarthy, Jessica A. L. Tucker, Tom J. Hazell
Physiological Reports (2024) Vol. 12, Iss. 16
Open Access | Times Cited: 6
Asprosin—A Fasting-Induced, Glucogenic, and Orexigenic Adipokine as a New Promising Player. Will It Be a New Factor in the Treatment of Obesity, Diabetes, or Infertility? A Review of the Literature
Agnieszka Mazur-Biały
Nutrients (2021) Vol. 13, Iss. 2, pp. 620-620
Open Access | Times Cited: 40
Asprosin, a novel pleiotropic adipokine implicated in fasting and obesity-related cardio-metabolic disease: Comprehensive review of preclinical and clinical evidence
Kiran Shabir, James E. Brown, Islam Afzal, et al.
Cytokine & Growth Factor Reviews (2021) Vol. 60, pp. 120-132
Open Access | Times Cited: 38
Serum levels of Asprosin in patients diagnosed with coronary artery disease (CAD): a case-control study
Nariman Moradi, Fatima Zahraa Fouani, Akram Vatannejad, et al.
Lipids in Health and Disease (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 29
The Effects of Asprosin on Exercise-Intervention in Metabolic Diseases
Lifei Liu, Yuhao Liu, Mei Huang, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 20
Acute effect of moderate and high-intensity interval exercises on asprosin and BDNF levels in inactive normal weight and obese individuals
Halil İ̇brahim Ceylan, Mehmet Öztürk, Deniz Öztürk, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Maximal Intensity Exercise Induces Adipokine Secretion and Disrupts Prooxidant–Antioxidant Balance in Young Men with Different Body Composition
Magdalena Więcek, Mateusz Mardyła, Jadwiga Szymura, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 350-350
Open Access
The Effect of Exercise on Spexin and Follistatin in Elderly Individuals
Elif Yıldırım Ayaz, Berna Dinçer, Gülser Cinbaz, et al.
Journal of Cachexia Sarcopenia and Muscle (2025) Vol. 16, Iss. 1
Open Access
Aerobic training and vitamin D supplementation effects on diabetes-related parameters in a rat model of type 2 diabetes
Zahra Hoseini, N Behpour, Rastegar Hoseini
BMC Sports Science Medicine and Rehabilitation (2025) Vol. 17, Iss. 1
Open Access
Asprosin Exerts Pro-Inflammatory Effects in THP-1 Macrophages Mediated via the Toll-like Receptor 4 (TLR4) Pathway
Kiran Shabir, Seley Gharanei, Sophie Orton, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 227-227
Open Access | Times Cited: 18
Exercise and Metabolic Health: The Emerging Roles of Novel Exerkines
Burak Yazgan, İbrahim Türkel, Berkay Özerkliğ, et al.
Current Protein and Peptide Science (2022) Vol. 23, Iss. 7, pp. 437-455
Closed Access | Times Cited: 17
Asprosin, a C-Terminal Cleavage Product of Fibrillin 1 Encoded by the <b><i>FBN1</i></b> Gene, in Health and Disease
Mehmet Akif Ovalı, İbrahim Bozgeyik
Molecular Syndromology (2022) Vol. 13, Iss. 3, pp. 175-183
Open Access | Times Cited: 16
Spirulina Supplementation with High-Intensity Interval Training Decreases Adipokines Levels and Cardiovascular Risk Factors in Men with Obesity
Rashmi Supriya, Maryam Delfan, Ayoub Saeidi, et al.
Nutrients (2023) Vol. 15, Iss. 23, pp. 4891-4891
Open Access | Times Cited: 10
Effects of exercise timing on metabolic health
José Ignacio Martínez‐Montoro, Javier Benítez‐Porres, Francisco J. Tinahones, et al.
Obesity Reviews (2023) Vol. 24, Iss. 10
Open Access | Times Cited: 9
Exercise-induced effects on asprosin and indices of atherogenicity and insulin resistance in males with metabolic syndrome: a randomized controlled trial
Agnieszka Suder, Karol Makiel, Aneta Targosz, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Asprosin: its function as a novel endocrine factor in metabolic-related diseases
Yang Zhang, Ping Yang, Xinliang Zhang, et al.
Journal of Endocrinological Investigation (2024) Vol. 47, Iss. 8, pp. 1839-1850
Closed Access | Times Cited: 3
Spexin: Its role, regulation, and therapeutic potential in the hypothalamus
Andy C. Tran, Wenyuan He, Jim T. C. Chen, et al.
Pharmacology & Therapeutics (2021) Vol. 233, pp. 108033-108033
Closed Access | Times Cited: 22
Novel insights on the role of spexin as a biomarker of obesity and related cardiometabolic disease
Seema Kumar, Robert T. Mankowski, Stephen D. Anton, et al.
International Journal of Obesity (2021) Vol. 45, Iss. 10, pp. 2169-2178
Closed Access | Times Cited: 20
Increased asprosin is associated with non-alcoholic fatty liver disease in children with obesity
Lujie Liu, Yu-Rong Kang, Yanfeng Xiao
World Journal of Pediatrics (2021) Vol. 17, Iss. 4, pp. 394-399
Closed Access | Times Cited: 20
Nordic Walking at Maximal Fat Oxidation Intensity Decreases Circulating Asprosin and Visceral Obesity in Women With Metabolic Disorders
Małgorzata Kantorowicz, Jadwiga Szymura, Zbigniew Szyguła, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 19
Emerging central and peripheral actions of spexin in feeding behavior, leptin resistance and obesity
Mei Yu, Mengxian Ju, Penghua Fang, et al.
Biochemical Pharmacology (2022) Vol. 202, pp. 115121-115121
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top